iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding iTeos Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 143 | 1 | 146 | +4 |
| Shares | 36.6M | 372 | 36.2M | −448.2K (−1.2%) |
| Value | $698.2M | $7.00K | $707.3M | +$9.12M (+1.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Octagon Capital Advisors LP | 445,000 | $8.69M | 1.35% |
| Saturn V Capital Management LLC | 342,071 | $7.03M | 5.83% |
| 683 Capital Management, LLC | 150,000 | $2.93M | 0.26% |
| Advisors Preferred, LLC | 90,973 | $1.69M | 0.74% |
| Braidwell LP | 71,585 | $1.40M | 0.05% |
| Sectoral Asset Management Inc | 57,762 | $1.13M | 0.22% |
| Vontobel Holding Ltd. | 57,762 | $1.13M | 0.01% |
| Ergoteles LLC | 40,468 | $790.3K | 0.03% |
| Guggenheim Capital LLC | 21,484 | $419.6K | 0.00% |
| UBS Asset Management Americas Inc | 21,137 | $412.8K | 0.00% |
| Endurant Capital Management LP | 21,041 | $410.9K | 0.17% |
| Tudor Investment Corp Et Al | 17,730 | $346.0K | 0.01% |
| Worth Venture Partners, LLC | 12,766 | $268.5K | 0.16% |
| Y-Intercept (Hong Kong) Ltd | 13,039 | $254.7K | 0.04% |
| Maryland State Retirement & Pension System | 10,038 | $196.0K | 0.01% |
| Sutton Wealth Advisors Inc. | 467 | $9.12K | 0.00% |
| Quadrant Capital Group LLC | 407 | $7.95K | 0.00% |
| Lindbrook Capital, LLC | 76 | $1.48K | 0.00% |
| Nisa Investment Advisors, LLC | 31 | $1.00K | 0.00% |
Sold out (15)
Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| SEI Investments Co | 96,529 | $1.84M |
| Two Sigma Advisers, LP | 86,200 | $1.64M |
| Schroder Investment Management Group | 66,609 | $1.27M |
| UBS Oconnor LLC | 57,500 | $1.09M |
| BNP Paribas Arbitrage, SA | 47,064 | $896.6K |
| Qube Research & Technologies Ltd | 29,242 | $557.0K |
| NinePointTwo Capital | 15,773 | $300.0K |
| Gotham Asset Management, LLC | 13,493 | $257.0K |
| Mutual of America Capital Management LLC | 4,883 | $93.0K |
| Robeco Institutional Asset Management B.V. | 3,014 | $57.0K |
| Ensign Peak Advisors, Inc | 2,280 | $43.0K |
| Allworth Financial LP | 32 | $1.00K |
| Meeder Asset Management Inc | 24 | $0 |
| First Horizon Advisors, Inc. | 35 | $0 |
| IFP Advisors, Inc | 22 | – |
Not filed for Q4 2022 yet (1)
Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 372 | $7.00K |